Whitehead Connects featuring Daphne Zohar

DZ-Daphne Zohar

Founder and CEO, PureTech Ventures

Daphne Zohar is the founder and CEO of PureTech, an operating company that identifies, invents and validates innovative technology that has the potential to address major healthcare needs.  Read more below.

“Balancing creativity with skepticism when forging a new path in biotech”

March 19, 2015
5:30 pm presentation; 6:30 pm networking reception
Whitehead Institute
Nine Cambridge Center, Cambridge, MA 02142

Eventbrite - Whitehead Connects with Daphne Zohar: "Balancing creativity with skepticism when forging a new path in biotech"

 

About Daphne Zohar

Daphne Zohar is the founder and CEO of PureTech, an operating company that identifies, invents and validates innovative technology that has the potential to address major healthcare needs. A successful entrepreneur, Ms. Zohar created PureTech and assembled a leading team to help implement her vision for the firm. She sits on the Boards of Directors of PureTech, Akili Interactive Labs, Vedanta Biosciences, Follica Inc., Mandara Sciences, Karuna Pharmaceuticals, and Tal Medical. She also sits on the Technology Development Fund Advisory Board at Children’s Hospital Boston and is an Editorial Advisor to Xconomy, a national technology news blog. Ms. Zohar was recognized by Fierce Biotech as one of the “Top 10 Women in Biotech,” MIT ‘s Tech Review as a TR35 Innovator, BioWorld as one of 28 leaders predicted to be the “movers and shakers” of the biotechnology industry over the next twenty years, and by the Boston Globe as one of the “Top 15 Innovators” and “10 most influential women in biotech.”
http://twitter.com/daphnezohar

About Whitehead Connects

Whitehead Connects is an initiative that brings renowned biology and biotech leaders to Whitehead Institute for an engaging presentation and dynamic networking opportunity for participants.  Following the free, public lecture participants will have the opportunity to meet Whitehead postdoctoral fellows and learn about their latest discoveries.